Loading news...
The latest trading day saw UnitedHealth Group (UNH) settling at $289.21, representing a -1.94% change from its previous close.
WINNETKA, Ill.--(BUSINESS WIRE)-- #HadleyHelps--Hadley is working with UnitedHealthcare Vision to help ensure that more people experiencing vision loss have access to emotional support resources alongside their traditional eye care. As part of the collaboration, UnitedHealthcare Vision will help broaden awareness of Adjusting & Coping Together, Hadley's free new video series focused on the emotional and psychological realities of vision loss. Vision loss affects more than 30 million people in the United S.
UnitedHealth is upgraded to 'Buy' as pessimism appears overdone and shares trade near a strong $300 support with compelling valuation metrics. UNH's scale, AI-driven cost efficiencies, and exposure to an aging U.S. population position it for long-term EPS and revenue recovery despite near-term stagnation. The stock offers a 3% forward dividend yield with a low 53% payout ratio and a solid record of dividend growth, appealing to income investors.
NEW YORK--(BUSINESS WIRE)---- $UNH #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of UnitedHealth Group Incorporated (NYSE: UNH) failed to manage UnitedHealth Group in an acceptable manner, breaching their fiduciary duties to UnitedHealth Group, and whether UnitedHealth Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 16, 2.
Davis R M Inc. lowered its holdings in UnitedHealth Group Incorporated (NYSE: UNH) by 62.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,556 shares of the healthcare conglomerate's stock after selling 9,343 shares during the period. Davis
111 Capital bought a new position in UnitedHealth Group Incorporated (NYSE: UNH) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 1,917 shares of the healthcare conglomerate's stock, valued at approximately $662,000. Other institutional investors and hedge funds also recently made changes
David Bahnsen, Chief Investment Officer, The Bahnsen Group shares the five stocks he thinks offer real upside as investors move away from Big Tech — and where he sees the strongest opportunities now. 00:00 Introduction 00:17 Dividend Strategy vs.
The medical care ratio is a key metric for UnitedHealth Group's business as it measures how efficient its operations are. The ratio has been rising, and it came in at over 89% last year.
UnitedHealth Group Incorporated (NYSE: UNH - Get Free Report) has earned an average rating of "Moderate Buy" from the twenty-eight analysts that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, seventeen have assigned a buy rating and one has assigned a
Billionaire Investor Ole Andreas Halvorsen worked for Julian Robertson's Tiger Management in the 1990s as the director of equities. Several research analysts from Tiger Management, including Halvorsen, went on to launch successful funds.
Andra AP fonden lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 48.1% in the third quarter, according to its most recent filing with the SEC. The firm owned 52,700 shares of the healthcare conglomerate's stock after selling 48,800 shares during the quarter. Andra AP fonden's holdings in UnitedHealth Group
Halvorsen opened several positions across industries in the recent quarter. The following two -- a travel stock and a healthcare player -- trade for reasonable prices.
DNB Asset Management AS increased its position in UnitedHealth Group Incorporated (NYSE: UNH) by 2.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 389,238 shares of the healthcare conglomerate's stock after purchasing an additional 9,513 shares during
UNH's scale and diversified model are likely to offer stronger upside than HUM as rising medical costs test managed care margins.
Dana Investment Advisors Inc. lessened its position in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 74.9% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,821 shares of the healthcare conglomerate's stock after selling 29,372 shares during the
Cary Street Partners Financial LLC decreased its stake in UnitedHealth Group Incorporated (NYSE: UNH) by 17.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,239 shares of the healthcare conglomerate's stock after selling 2,414 shares during
UnitedHealth (UNH) stock has dropped by 23.1% in under a month, from $356 on January 23, 2026 to $274 now, primarily due to a "perfect storm" of disappointing 2026 financial guidance and a major regulatory shock, with the Trump administration proposing essentially flat reimbursement rates for 2027 (an increase of only 0.09%), which was significantly lower than industry models.
--(BUSINESS WIRE)--UNH Quarterly Dividend Announcement.
Empirical Asset Management LLC lifted its position in UnitedHealth Group Incorporated (NYSE: UNH) by 142.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,901 shares of the healthcare conglomerate's stock after purchasing an additional 3,465 shares during the
UnitedHealth Group Incorporated's UNH health benefits arm, UnitedHealthcare, remains the company's primary revenue engine, yet profitability pressures continue to weigh on investor sentiment. Although the segment's revenues climbed 15.7% in 2025 to $344.9 billion, adjusted operating earnings fell sharply by 41.1% to $9.6 billion, reflecting reduced Medicare funding and persistently elevated medical cost trends.